Last10K.com

Nexien Biopharma, Inc. (NXEN) SEC Filing 8-K Material Event for the period ending Tuesday, January 18, 2022

Nexien Biopharma, Inc.

CIK: 1625288 Ticker: NXEN

View differences made from one to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..

Continue

Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Nexien Biopharma, Inc. provided additional information to their SEC Filing as exhibits

Ticker: NXEN
CIK: 1625288
Form Type: 8-K Corporate News
Accession Number: 0001493152-22-001830
Submitted to the SEC: Fri Jan 21 2022 1:04:34 PM EST
Accepted by the SEC: Fri Jan 21 2022
Period: Tuesday, January 18, 2022
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation
  4. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nxen/0001493152-22-001830.htm